Literature DB >> 9000652

FN18-CRM9 immunotoxin promotes tolerance in primate renal allografts.

S J Knechtle1, D Vargo, J Fechner, Y Zhai, J Wang, M J Hanaway, J Scharff, H Hu, L Knapp, D Watkins, D M Neville.   

Abstract

BACKGROUND: Transplant tolerance, rather than immunity, may be favored in the setting of a lower mature lymphoid mass in the recipient induced by anti-T cell agents. A novel immunosuppressive agent, FN18-CRM9, known to specifically kill T cells with great potency, was evaluated in a transplant model.
METHODS: In order to ablate recipient T cells, the immunotoxin FN18-CRM9 was administered to rhesus monkey recipients of MHC-mismatched renal allografts. Donor lymphocytes were injected intrathymically into some animals.
RESULTS: All monkeys with T-cell depletion by immunotoxin had prolonged allograft survival, and tolerance confirmed by skin grafting has been confirmed in five of six long-surviving recipients.
CONCLUSIONS: In this clinically relevant model, profound but transient T-cell depletion by a single agent substantially promotes tolerance.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9000652     DOI: 10.1097/00007890-199701150-00002

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  27 in total

Review 1.  Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organs.

Authors:  Alberto Sánchez-Fueyo; Terry B Strom
Journal:  Gastroenterology       Date:  2010-11-09       Impact factor: 22.682

2.  Depletion of CD8 memory T cells for induction of tolerance of a previously transplanted kidney allograft.

Authors:  I Koyama; O Nadazdin; S Boskovic; T Ochiai; R N Smith; M Sykes; H Sogawa; T Murakami; T B Strom; R B Colvin; D H Sachs; G Benichou; A B Cosimi; T Kawai
Journal:  Am J Transplant       Date:  2007-02-07       Impact factor: 8.086

Review 3.  Lymphodepletional strategies in transplantation.

Authors:  Eugenia Page; Jean Kwun; Byoungchol Oh; Stuart Knechtle
Journal:  Cold Spring Harb Perspect Med       Date:  2013-07-01       Impact factor: 6.915

4.  CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates.

Authors:  A D Kirk; D M Harlan; N N Armstrong; T A Davis; Y Dong; G S Gray; X Hong; D Thomas; J H Fechner; S J Knechtle
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

5.  A modern Cosmas and Damian: Sir Roy Calne and Thomas Starzl receive the 2012 Lasker~Debakey Clinical Medical Research Award.

Authors:  Jillian Hurst
Journal:  J Clin Invest       Date:  2012-10       Impact factor: 14.808

6.  Stable mixed chimerism and tolerance using a nonmyeloablative preparative regimen in a large-animal model.

Authors:  C A Huang; Y Fuchimoto; R Scheier-Dolberg; M C Murphy; D M Neville; D H Sachs
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

Review 7.  Induction of tolerance in clinical kidney transplantation.

Authors:  Tatsuo Kawai; A Benedict Cosimi
Journal:  Clin Transplant       Date:  2010-07       Impact factor: 2.863

8.  Pulmonary angiography for the diagnosis of thromboembolic events in the non-human primate.

Authors:  Ziv Neeman; Boaz Hirshberg; Michael G Tal; Bradford J Wood; David M Harlan
Journal:  Transplantation       Date:  2004-10-15       Impact factor: 4.939

9.  CD40-ligand in primate cardiac allograft and viral immunity.

Authors:  R N Pierson; J E Crowe; S Pfeiffer; J Atkinson; A Azimzadeh; G G Miller
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

10.  The evolving role of alemtuzumab (Campath-1H) in renal transplantation.

Authors:  Phuong-Thu T Pham; Gerald S Lipshutz; Phuong-Truc T Pham; Joseph Kawahji; Jennifer S Singer; Phuong-Chi T Pham
Journal:  Drug Des Devel Ther       Date:  2009-09-21       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.